DHI Group: Q4 Earnings Insights

DHI Group (NYSE:DHX) reported its Q4 earnings results on Wednesday, February 7, 2024 at 04:15 PM. Here’s what…

DHI Group (NYSE:DHX) reported its Q4 earnings results on Wednesday, February 7, 2024 at 04:15 PM.

Here’s what investors need to know about the announcement.

Earnings

DHI Group reported in-line EPS of $0.04 versus an estimate of $0.04.

Revenue was down $2.48 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 4.76% increase in the share price the next day.

Here’s a look at DHI Group’s past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate 0.03 -0.02 -0.02 0
EPS Actual 0.03 0.02 0 0.01
Revenue Estimate 38.52M 38.69M 37.47M 39.02M
Revenue Actual 37.43M 38.54M 38.62M 39.76M

To track all earnings releases for DHI Group visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Aurora Touts 41% YoY Increase In International Medical Cannabis Q3 Revenue, Expands In Australia Via New Acquisition

Canadian medical cannabis company Aurora Cannabis reported its financial and operational results for Q3 2024. Net revenue increased to CAD64.4m ($42m), up from CAD61.1m in the same quarter the previous year. Medical cannabis net revenue rose by 16% to CAD45.1m, representing 70% of Aurora's consolidated net revenue. Gross profit reached CAD19.8m, up from CAD3.7m in Q3 2022, with adjusted gross profit before fair value adjustments increasing to CAD32.4m from CAD28m. The company recorded a CAD25.5m net loss compared to CAD67.2m in the same quarter in the previous year. Adjusted EBITDA came in at CAD4.3m, up from CAD3m. Miguel Martin, CEO of Aurora, said the company's international medical net revenue had seen year-on-year growth of 41%.

ACB